SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Botox® May Help Spinal Cord-Injured or Multiple Sclerosis Patients with Overactive Bladder, Baylor College of Medicine Study
September 21, 2007
 · 
1 min read
Lone Star Bio
Experts Explore Ethical, Legal Implications of Personal Genomics
September 21, 2007
 · 
1 min read
Lone Star Bio
Breath Test Detects H. Pylori Bacteria in Stomach, Baylor College of Medicine Study
September 21, 2007
 · 
1 min read
Drug Development
Smart Insulin Nanostructures Pass Feasibility Test, University of Texas Study Reports
September 21, 2007
 · 
1 min read
Lone Star Bio
Radiation Therapy Technique Reduces Length of Prostate Cancer Treatment
September 20, 2007
 · 
1 min read
Lone Star Bio
UT Southwestern Medical Center Earns $34 Million National Institutes of Health (NIH) Grant to Foster Patient-Oriented Research
September 20, 2007
 · 
1 min read
Lone Star Bio
Cholesterol Byproduct Blocks Heart-Health Benefits of Estrogen, UT Southwestern Medical Center Study Finds
September 17, 2007
 · 
1 min read
Lone Star Bio
M. D. Anderson Cancer Center-Led Team Reports Possible Key to Autoimmune Disease
September 17, 2007
 · 
1 min read
Drug Development
Researchers Test Old Drug with New Hopes for Pre-Eclampsia Cure
September 14, 2007
 · 
1 min read
Lone Star Bio
Metabolic Syndrome Heightens Risk for Development of Uric-Acid Kidney Stones
September 13, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More